Factor Xa Archives - Medical Conferences

EPIC-CAD: What is the best antithrombotic approach in high-risk AF plus stable CAD?

Presented By

Dr Gi-Byoung Nam, Ulsan University Hospital, South Korea

Trial

Phase 4, EPIC-CAD

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:23

OCEANIC-AF: Asundexian inferior to apixaban for ischaemic stroke prevention in AF

Presented By

Dr Manesh Patel, Duke Clinical Research Institute, USA

Trial

Phase 3, OCEANIC-AF

Conference

ESC 2024

Type

Peer-reviewed article

7 November 2024 13:16

Rheumatic heart disease-associated AF: standard-of-care holds ground

Presented By

Prof. Ganesan Karthikeyan, All India Institute of Medical Sciences, India

Trial

Phase 3, INVICTUS

Conference

ESC 2022

Type

Peer-reviewed article

27 October 2022 14:14

Apixaban outcomes similar to current standard of care following TAVR

Presented By

Prof. Jean-Philippe Collet, Sorbonne Université, France

Trial

ATLANTIS

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:14

DOACs and bleeding: the role of antidotes

Presented By

Dr Kaveshree Govender, Milpark Hospital, South Africa

Trial

RE-VERSE AD

Conference

EHRA 2021

Type

Peer-reviewed article

16 June 2021 10:26